Stay updated on CPX-351 and Quizartinib in AML Clinical Trial
Sign up to get notified when there's something new on the CPX-351 and Quizartinib in AML Clinical Trial page.

Latest updates to the CPX-351 and Quizartinib in AML Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe study record history adds a new revision entry v3.6.6. The v3.6.5 entry has been removed, updating the revision log to reflect the latest version of the record.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedThe study record history now shows Revision: v3.6.5 as the latest entry, replacing Revision: v3.6.4, indicating an update to the page's revision history.SummaryDifference0.1%

- Check55 days agoChange DetectedThe study history page now shows a new revision tag v3.6.4, replacing the previous v3.6.3, signaling a software update to the site’s interface.SummaryDifference0.1%

- Check77 days agoChange DetectedThe Record History now lists the latest software revision as v3.6.3, replacing the previous v3.6.2 entry to reflect a deployment update.SummaryDifference0.1%

- Check84 days agoChange DetectedNew revision entry v3.6.2 has been added to the study record history, indicating an updated version of the record. The previous revision v3.6.0 is removed in this update, reflecting the revised history list.SummaryDifference0.1%

- Check98 days agoChange DetectedThe latest history entry records that the study is no longer enrolling participants and notes a revision to v3.6.0; the previous revision v3.5.5 is removed from the visible history.SummaryDifference0.3%

Stay in the know with updates to CPX-351 and Quizartinib in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CPX-351 and Quizartinib in AML Clinical Trial page.